BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 19895988)

  • 1. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
    Werfel T
    J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
    [No Abstract]   [Full Text] [Related]  

  • 2. Sublingual immunotherapy.
    Corrigan C
    J Allergy Clin Immunol; 2007 Feb; 119(2):515; author reply 515-7. PubMed ID: 17187850
    [No Abstract]   [Full Text] [Related]  

  • 3. New clinical documentation on ALK grass allergen tablet.
    Bachert C
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():57-60. PubMed ID: 19221621
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of sublingual immunotherapy in children.
    Bufe A
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():61-3. PubMed ID: 19221622
    [No Abstract]   [Full Text] [Related]  

  • 5. Sublingual immunotherapy: allergen specific or placebo effect?
    Kette F; Smith W
    J Allergy Clin Immunol; 2011 Aug; 128(2):430; author reply 430-2. PubMed ID: 21665261
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoid sublingual immunotherapy.
    Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?
    Senti G; von Moos S; Kündig TM
    Allergy; 2011 Jun; 66(6):798-809. PubMed ID: 21518374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.
    Dahl R; Kapp A; Colombo G; de Monchy JG; Rak S; Emminger W; Rivas MF; Ribel M; Durham SR
    J Allergy Clin Immunol; 2006 Aug; 118(2):434-40. PubMed ID: 16890769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of the effectiveness of 2 methods of specific immunotherapy of pollinoses].
    Polsacheva OV; Gushchin IS; Poroshina IuA; Chitaeva VG; Shustova VI
    Ter Arkh; 1986; 58(4):120-3. PubMed ID: 2424113
    [No Abstract]   [Full Text] [Related]  

  • 11. [Allergen-specific immunotherapy in the treatment of pollen allergy].
    Mailhol C; Didier A
    Rev Mal Respir; 2013 Feb; 30(2):142-51. PubMed ID: 23419445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.
    Worm M
    Eur Ann Allergy Clin Immunol; 2006 Dec; 38(10):355-60. PubMed ID: 17274520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous versus sublingual immunotherapy.
    Lin CH; Alandijani S; Lockey RF
    Expert Rev Clin Immunol; 2016 Aug; 12(8):801-3. PubMed ID: 27253418
    [No Abstract]   [Full Text] [Related]  

  • 14. [Apropos of sublingual specific immunotherapy].
    Sabbah A
    Allerg Immunol (Paris); 1998 Apr; 30(4):97-8. PubMed ID: 9631689
    [No Abstract]   [Full Text] [Related]  

  • 15. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage.
    Durham SR; Riis B
    Allergy; 2007 Aug; 62(8):954-7. PubMed ID: 17620075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis.
    Agostinis F; Forti S; Di Berardino F
    Allergy; 2010 Mar; 65(3):410-1. PubMed ID: 19804450
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specific immunotherapy with tablets].
    Krankenpfl J; 2005; 43(7-10):260. PubMed ID: 16515331
    [No Abstract]   [Full Text] [Related]  

  • 19. Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis.
    Patterson AM; Bonny AE; Shiels WE; Erwin EA
    Ann Allergy Asthma Immunol; 2016 Feb; 116(2):168-70. PubMed ID: 26706294
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pollen-induced allergy. Programming and monitoring of specific immunotherapy].
    Obtułowicz K
    Folia Med Cracov; 1988; 29(1-2):21-48. PubMed ID: 3255656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.